Advertisement

Obesity Surgery

, Volume 23, Issue 12, pp 2068–2074 | Cite as

Effectiveness of Intragastric Balloon Treatment for Obese Patients: One-Year Follow-up After Balloon Removal

  • Chi-Ming Tai
  • Hung-Yen Lin
  • Yung-Chieh Yen
  • Chih-Kun Huang
  • Wan-Ling Hsu
  • Ya-Wei Huang
  • Chi-Yang Chang
  • Hsiu-Po Wang
  • Lein-Ray MoEmail author
Original Contributions

Abstract

Background

The Bioenterics Intragastric Balloon (BIB) is effective for weight loss. However, comparisons of its effectiveness between groups with different body mass index (BMI) are rare. This study compared the effectiveness of BIB treatment in patients with BMI <32 kg/m2 and those with BMI ≧32 kg/m2 at the time of BIB removal and at 1 year later.

Methods

Between April 2009 and June 2011, 28 obese patients who completed a full course of BIB treatment were enrolled. There are 16 patients with BMI <32 and 12 with BMI ≧32. Patients who lost more than 20 % of excess weight (% EWL) were categorized as responders.

Results

The BMI significantly fell from 32.4 ± 3.7 to 28.5 ± 3.7 kg/m2 (P < 0.01) at the time of BIB removal. All biochemical measurements except for cholesterol level were significantly improved. The median value of %EWL of all patients at BIB removal was 40.1, and 20 patients (71.4 %) were responders. Adherence to dietitian counseling was significantly better in responders than in non-responders (85 vs. 25 %, respectively; P < 0.01). The percentage of responders at 1 year after BIB removal was significantly higher among patients with BMI <32 than those with ≧32 (62.5 vs. 16.7 %, respectively; P = 0.02).

Conclusions

BIB placement can achieve significant weight loss and improvement of co-morbidities in obese patients. Better adherence to dietitian counseling is associated with better response. Patients with BMI <32 maintain better weight loss at 1 year after BIB removal.

Keywords

Weight loss Gastric balloon Body mass index Obesity 

Abbreviations

BIB

BioEnterics Intragastric Balloon

BMI

Body mass index

WC

Waist circumference

AST

Aspartate aminotransferase

ALT

Alanine aminotransferase

HDL

High-density lipoprotein

LDL

low-density lipoprotein

LA

classification Los Angeles classification

EWL

Excess weight loss

Notes

Acknowledgments

This study was supported by a Project of the E-Da Hospital, Grant Number EDAHP101017.

Conflict of Interest

All contributing authors declare that they have no conflicts of interest.

References

  1. 1.
    James WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263:336–52.PubMedCrossRefGoogle Scholar
  2. 2.
    Delinsky SS, Latner JD, Wilson GT. Binge eating and weight loss in a self-help behavior modification program. Obesity (Silver Spring). 2006;14:1244–9.CrossRefGoogle Scholar
  3. 3.
    Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.PubMedCrossRefGoogle Scholar
  4. 4.
    Goldfeder LB, Ren CJ, Gill JR. Fatal complications of bariatric surgery. Obes Surg. 2006;16:1050–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005;15:751–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Mui WL, So WY, Yau PY, et al. Intragastric balloon in ethnic obese Chinese: initial experience. Obes Surg. 2006;16:308–13.PubMedCrossRefGoogle Scholar
  9. 9.
    Ganesh R, Rao AD, Baladas HG, et al. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singap Med J. 2007;48:227–31.Google Scholar
  10. 10.
    Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement. Obes Surg. 2009;19:791–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32.PubMedCrossRefGoogle Scholar
  12. 12.
    Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRefGoogle Scholar
  14. 14.
    WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRefGoogle Scholar
  15. 15.
    Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903.PubMedCrossRefGoogle Scholar
  17. 17.
    Dansinger ML, Tatsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147:41–50.PubMedCrossRefGoogle Scholar
  18. 18.
    Puglisi F, Antonucci N, Capuano P, et al. Intragastric balloon and binge eating. Obes Surg. 2007;17:504–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Genco A, Lopez-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23:515–21.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Chi-Ming Tai
    • 1
    • 2
  • Hung-Yen Lin
    • 1
    • 3
  • Yung-Chieh Yen
    • 1
    • 3
  • Chih-Kun Huang
    • 1
    • 4
  • Wan-Ling Hsu
    • 1
  • Ya-Wei Huang
    • 1
  • Chi-Yang Chang
    • 2
  • Hsiu-Po Wang
    • 5
  • Lein-Ray Mo
    • 2
    Email author
  1. 1.Bariatric and Metabolic International Surgery Center, E-Da HospitalI-Shou UniversityKaohsiungTaiwan
  2. 2.Department of Internal Medicine, E-Da HospitalI-Shou UniversityKaohsiung 824Taiwan
  3. 3.Department of Psychiatry, E-Da HospitalI-Shou UniversityKaohsiungTaiwan
  4. 4.Department of Surgery, E-Da HospitalI-Shou UniversityKaohsiungTaiwan
  5. 5.Department of Internal Medicine, National Taiwan University HospitalNational Taiwan UniversityTaipeiTaiwan

Personalised recommendations